Annual Cash & Cash Equivalents
$15.50 M
-$9.22 M-37.32%
31 December 2023
Summary:
Achieve Life Sciences annual cash & cash equivalents is currently $15.50 million, with the most recent change of -$9.22 million (-37.32%) on 31 December 2023. During the last 3 years, it has fallen by -$20.36 million (-56.78%). ACHV annual cash & cash equivalents is now -75.03% below its all-time high of $62.05 million, reached on 31 December 2009.ACHV Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$9.54 M
-$5.21 M-35.32%
30 September 2024
Summary:
Achieve Life Sciences quarterly cash and cash equivalents is currently $9.54 million, with the most recent change of -$5.21 million (-35.32%) on 30 September 2024. Over the past year, it has dropped by -$10.32 million (-51.97%). ACHV quarterly cash and cash equivalents is now -85.77% below its all-time high of $67.05 million, reached on 30 June 2006.ACHV Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACHV Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.3% | -52.0% |
| 3 y3 years | -56.8% | -71.3% |
| 5 y5 years | +62.9% | +29.4% |
ACHV Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -64.0% | at low | -85.6% | at low |
| 5 y | 5 years | -64.0% | +62.9% | -85.6% | +29.4% |
| alltime | all time | -75.0% | >+9999.0% | -85.8% | >+9999.0% |
Achieve Life Sciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $9.54 M(-35.3%) |
| June 2024 | - | $14.76 M(-77.8%) |
| Mar 2024 | - | $66.40 M(+328.5%) |
| Dec 2023 | $15.50 M(-37.3%) | $15.50 M(-22.0%) |
| Sept 2023 | - | $19.87 M(-20.6%) |
| June 2023 | - | $25.02 M(+51.5%) |
| Mar 2023 | - | $16.51 M(-33.2%) |
| Dec 2022 | $24.72 M(-42.5%) | $24.72 M(+35.9%) |
| Sept 2022 | - | $18.20 M(-38.1%) |
| June 2022 | - | $29.38 M(-19.2%) |
| Mar 2022 | - | $36.34 M(-15.5%) |
| Dec 2021 | $43.02 M(+20.0%) | $43.02 M(+29.1%) |
| Sept 2021 | - | $33.31 M(-20.7%) |
| June 2021 | - | $42.00 M(+41.7%) |
| Mar 2021 | - | $29.64 M(-17.3%) |
| Dec 2020 | $35.85 M(+115.2%) | $35.85 M(+60.1%) |
| Sept 2020 | - | $22.39 M(+84.9%) |
| June 2020 | - | $12.11 M(-0.4%) |
| Mar 2020 | - | $12.16 M(-27.1%) |
| Dec 2019 | $16.66 M(+75.1%) | $16.66 M(+126.0%) |
| Sept 2019 | - | $7.38 M(-29.4%) |
| June 2019 | - | $10.45 M(+42.7%) |
| Mar 2019 | - | $7.32 M(-23.1%) |
| Dec 2018 | $9.52 M(+80.1%) | $9.52 M(-19.1%) |
| Sept 2018 | - | $11.76 M(-23.1%) |
| June 2018 | - | $15.28 M(+266.9%) |
| Mar 2018 | - | $4.17 M(-21.2%) |
| Dec 2017 | $5.28 M(>+9900.0%) | $5.28 M(-34.1%) |
| Sept 2017 | - | $8.02 M(-42.4%) |
| June 2017 | - | $13.92 M(-11.3%) |
| Mar 2017 | - | $15.69 M(>+9900.0%) |
| Dec 2016 | $15.00 K(-100.0%) | $15.00 K(-99.9%) |
| Sept 2016 | - | $11.80 M(+11.5%) |
| June 2016 | - | $10.58 M(-44.1%) |
| Mar 2016 | - | $18.91 M(-44.9%) |
| Dec 2015 | $34.31 M(+23.0%) | $34.31 M(-19.2%) |
| Sept 2015 | - | $42.48 M(-11.5%) |
| June 2015 | - | $48.00 M(+89.9%) |
| Mar 2015 | - | $25.28 M(-9.4%) |
| Dec 2014 | $27.90 M(+91.2%) | $27.90 M(-43.0%) |
| Sept 2014 | - | $48.95 M(+20.5%) |
| June 2014 | - | $40.61 M(+41.9%) |
| Mar 2014 | - | $28.63 M(+96.2%) |
| Dec 2013 | $14.59 M(-19.3%) | $14.59 M(+12.7%) |
| Sept 2013 | - | $12.95 M(-30.9%) |
| June 2013 | - | $18.75 M(+0.6%) |
| Mar 2013 | - | $18.63 M(+3.1%) |
| Dec 2012 | $18.07 M(-36.6%) | $18.07 M(+59.1%) |
| Sept 2012 | - | $11.36 M(-17.9%) |
| June 2012 | - | $13.84 M(-75.7%) |
| Mar 2012 | - | $56.85 M(+99.4%) |
| Dec 2011 | $28.52 M(+21.2%) | $28.52 M(+81.4%) |
| Sept 2011 | - | $15.72 M(-24.7%) |
| June 2011 | - | $20.88 M(+198.3%) |
| Mar 2011 | - | $7.00 M(-70.3%) |
| Dec 2010 | $23.53 M | $23.53 M(+99.8%) |
| Sept 2010 | - | $11.78 M(-64.3%) |
| June 2010 | - | $33.01 M(-27.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $45.48 M(-26.7%) |
| Dec 2009 | $62.05 M(+714.5%) | $62.05 M(+517.2%) |
| Sept 2009 | - | $10.05 M(+139.6%) |
| June 2009 | - | $4.20 M(-55.3%) |
| Mar 2009 | - | $9.39 M(+23.3%) |
| Dec 2008 | $7.62 M(+16.6%) | $7.62 M(+26.0%) |
| Sept 2008 | - | $6.05 M(+5.6%) |
| June 2008 | - | $5.73 M(-67.5%) |
| Mar 2008 | - | $17.60 M(+169.3%) |
| Dec 2007 | $6.54 M(-81.7%) | $6.54 M(+185.6%) |
| Sept 2007 | - | $2.29 M(-10.1%) |
| June 2007 | - | $2.54 M(-83.8%) |
| Mar 2007 | - | $15.76 M(-56.0%) |
| Dec 2006 | $35.77 M(-27.5%) | $35.77 M(-19.0%) |
| Sept 2006 | - | $44.19 M(-34.1%) |
| June 2006 | - | $67.05 M(+39.0%) |
| Mar 2006 | - | $48.23 M(-2.2%) |
| Dec 2005 | $49.32 M(>+9900.0%) | $49.32 M(+118.7%) |
| Sept 2005 | - | $22.55 M(+694.0%) |
| June 2005 | - | $2.84 M(-26.6%) |
| Mar 2005 | - | $3.87 M(+827.6%) |
| Dec 2004 | $416.80 K(-75.6%) | $416.80 K(-75.7%) |
| Sept 2004 | - | $1.71 M(-94.0%) |
| June 2004 | - | $28.73 M(+70.0%) |
| Mar 2004 | - | $16.90 M(+888.8%) |
| Dec 2003 | $1.71 M(+352.1%) | $1.71 M(-92.3%) |
| Sept 2003 | - | $22.15 M(+96.5%) |
| June 2003 | - | $11.27 M(+234.7%) |
| Mar 2003 | - | $3.37 M(+790.9%) |
| Dec 2002 | $378.00 K(-16.9%) | $378.00 K(-11.0%) |
| Sept 2002 | - | $424.60 K(-98.1%) |
| June 2002 | - | $22.11 M(+654.9%) |
| Mar 2002 | - | $2.93 M(+543.5%) |
| Dec 2001 | $455.10 K(-93.2%) | $455.10 K(-86.9%) |
| Sept 2001 | - | $3.47 M(-26.3%) |
| June 2001 | - | $4.71 M(-34.1%) |
| Mar 2001 | - | $7.14 M(+6.7%) |
| Dec 2000 | $6.70 M(+13.6%) | $6.70 M(+10.4%) |
| Sept 2000 | - | $6.06 M(-22.8%) |
| June 2000 | - | $7.85 M(+6.9%) |
| Mar 2000 | - | $7.34 M(+24.6%) |
| Dec 1999 | $5.89 M(-65.3%) | $5.89 M(-23.5%) |
| Sept 1999 | - | $7.70 M(+42.6%) |
| June 1999 | - | $5.40 M(+14.9%) |
| Mar 1999 | - | $4.70 M(-72.4%) |
| Dec 1998 | $17.00 M(+220.8%) | $17.00 M(+157.6%) |
| Sept 1998 | - | $6.60 M(-5.7%) |
| June 1998 | - | $7.00 M(+34.6%) |
| Mar 1998 | - | $5.20 M(-1.9%) |
| Dec 1997 | $5.30 M(-26.4%) | $5.30 M(-27.4%) |
| Sept 1997 | - | $7.30 M(+14.1%) |
| June 1997 | - | $6.40 M(+12.3%) |
| Mar 1997 | - | $5.70 M(-20.8%) |
| Dec 1996 | $7.20 M(+26.3%) | $7.20 M(+22.0%) |
| Sept 1996 | - | $5.90 M(-37.2%) |
| June 1996 | - | $9.40 M(+88.0%) |
| Mar 1996 | - | $5.00 M(-12.3%) |
| Dec 1995 | $5.70 M | $5.70 M(+1325.0%) |
| Sept 1995 | - | $400.00 K |
FAQ
- What is Achieve Life Sciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Achieve Life Sciences?
- What is Achieve Life Sciences annual cash & cash equivalents year-on-year change?
- What is Achieve Life Sciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Achieve Life Sciences?
- What is Achieve Life Sciences quarterly cash and cash equivalents year-on-year change?
What is Achieve Life Sciences annual cash & cash equivalents?
The current annual cash & cash equivalents of ACHV is $15.50 M
What is the all time high annual cash & cash equivalents for Achieve Life Sciences?
Achieve Life Sciences all-time high annual cash & cash equivalents is $62.05 M
What is Achieve Life Sciences annual cash & cash equivalents year-on-year change?
Over the past year, ACHV annual cash & cash equivalents has changed by -$9.22 M (-37.32%)
What is Achieve Life Sciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ACHV is $9.54 M
What is the all time high quarterly cash and cash equivalents for Achieve Life Sciences?
Achieve Life Sciences all-time high quarterly cash and cash equivalents is $67.05 M
What is Achieve Life Sciences quarterly cash and cash equivalents year-on-year change?
Over the past year, ACHV quarterly cash and cash equivalents has changed by -$10.32 M (-51.97%)